National Center for Children's Health/Beijing Children's Hospital, Capital Medical University/Laboratory of Dermatology, Beijing Pediatric Research Institute/National Key Discipline of Pediatrics (Capital Medical University)/Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing 100045, China (Email: yaokaihu@bch.com.cn)
Abstract The guideline for the diagnosis and treatment of monkeypox (2022 edition) issued by National Health Commission of the People's Republic of China introduces the key knowledge of the diagnosis and treatment of human monkeypox (HMPX) and does not systematically introduce the sampling methods and requirements of specimens for HMPX etiology testing and the discrepancy in diagnostic criteria between China and overseas. However, the doctors who are not engaged in dermatology lack understanding of the sampling methods and requirements of specimens for laboratory diagnosis of HMPX, and there are few relevant references available. This article collects the information on the diagnosis and treatment of HMPX, so as to provide a reference for learning, understanding, and application of this guideline. Citation:Chinese Journal of Contemporary Pediatrics, 2022, 24(9): 960-966
1 Centers for Disease Control and Prevention. 2022 monkeypox outbreak global map[EB/OL]. (2022-07-28)[2022-07-29]. https://www.cdc.gov/poxvirus/monkeypox/response/2022/world-map.html.
2 World Health Organization. WHO Director-General's statement at the press conference following IHR Emergency Committee regarding the multi-country outbreak of monkeypox - 23 July 2022[EB/OL]. (2022-07-23)[2022-07-26]. https://www.who.int/director-general/speeches/detail/who-director-general-s-statement-on-the-press-conference-following-IHR-emergency-committee-regarding-the-multi--country-outbreak-of-monkeypox--23-july-2022.
4 Centers for Disease Control and Prevention. Specimen collection[EB/OL]. (2016-12-01)[2022-06-13]. https://www.cdc.gov/smallpox/lab-personnel/specimen-collection/index.html.
6 European Centre for Disease Prevention and Control, World Health Organization European Region. Joint ECDC-WHO regional office for Europe monkeypox surveillance bulletin[EB/OL]. (2022-07-20)[2022-07-27]. https://monkeypoxreport.ecdc.europa.eu/.
Hughes CM, Liu L, Davidson WB, et al. A tale of two viruses: coinfections of monkeypox and varicella zoster virus in the Democratic Republic of Congo[J]. Am J Trop Med Hyg, 2020, 104(2): 604-611. PMID: 33289470. PMCID: PMC7866336. DOI: 10.4269/ajtmh.20-0589.
10 Centers for Disease Control and Prevention. Test procedure: monkeypox virus generic real-time PCR test[EB/OL]. (2022-06-06)[2022-06-13]. https://www.cdc.gov/poxvirus/monkeypox/pdf/PCR-Diagnostic-Protocol-508.pdf.
Li Y, Zhao H, Wilkins K, et al. Real-time PCR assays for the specific detection of monkeypox virus West African and Congo Basin strain DNA[J]. J Virol Methods, 2010, 169(1): 223-227. PMID: 20643162. DOI: 10.1016/j.jviromet.2010.07.012.
Huhn GD, Bauer AM, Yorita K, et al. Clinical characteristics of human monkeypox, and risk factors for severe disease[J]. Clin Infect Dis, 2005, 41(12): 1742-1751. PMID: 16288398. DOI: 10.1086/498115.
Mbala PK, Huggins JW, Riu-Rovira T, et al. Maternal and fetal outcomes among pregnant women with human monkeypox infection in the Democratic Republic of Congo[J]. J Infect Dis, 2017, 216(7): 824-828. PMID: 29029147. DOI: 10.1093/infdis/jix260.
Tutu van Furth AM, van der Kuip M, van Els AL, et al. Paediatric monkeypox patient with unknown source of infection, the Netherlands, June 2022[J]. Euro Surveill, 2022, 27(29): 2200552. PMID: 35866435. DOI: 10.2807/1560-7917.ES.2022.27.29.2200552.
Nguyen PY, Ajisegiri WS, Costantino V, et al. Reemergence of human monkeypox and declining population immunity in the context of urbanization, Nigeria, 2017-2020[J]. Emerg Infect Dis, 2021, 27(4): 1007-1014. PMID: 33756100. PMCID: PMC8007331. DOI: 10.3201/eid2704.203569.
Nolen LD, Osadebe L, Katomba J, et al. Extended human-to-human transmission during a monkeypox outbreak in the Democratic Republic of the Congo[J]. Emerg Infect Dis, 2016, 22(6): 1014-1021. PMID: 27191380. PMCID: PMC4880088. DOI: 10.3201/eid2206.150579.
Mande G, Akonda I, De Weggheleire A, et al. Enhanced surveillance of monkeypox in Bas-Uélé, Democratic Republic of Congo: the limitations of symptom-based case definitions[J]. Int J Infect Dis, 2022, 122: 647-655. PMID: 35809857. DOI: 10.1016/j.ijid.2022.06.060.
20 World Health Organization. Multi-country monkeypox outbreak: situation update[EB/OL]. (2022-06-27)[2022-07-15]. https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON396.
Thornhill JP, Barkati S, Walmsley S, et al. Monkeypox virus infection in humans across 16 countries-April-June 2022[J]. N Engl J Med, 2022. Epub ahead of print. PMID: 35866746. DOI: 10.1056/NEJMoa2207323.
Johnston SC, Johnson JC, Stonier SW, et al. Cytokine modulation correlates with severity of monkeypox disease in humans[J]. J Clin Virol, 2015, 63: 42-45. PMID: 25600603. DOI: 10.1016/j.jcv.2014.12.001.
Petersen E, Kantele A, Koopmans M, et al. Human monkeypox: epidemiologic and clinical characteristics, diagnosis, and prevention[J]. Infect Dis Clin North Am, 2019, 33(4): 1027-1043. PMID: 30981594. DOI: 10.1016/j.idc.2019.03.001.